Active Ingredient(s): Istradefylline
FDA Approved: * August 27, 2019
Pharm Company: * KYOWA KIRIN
Category: Parkinsons

Istradefylline, sold under the brand name Nourianz, is a medication used as an add-on treatment to levodopa/carbidopa in adults with Parkinson's disease (PD) experiencing "off" episodes.[2][3][4] Istradefylline reduces "off" periods resulting from long-term treatment with the antiparkinson drug levodopa.[2] An "off" episode is a time when a patient's medications are not working well, causing an increase in PD symptoms, such as tr... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Nourianz 20 mg Oral Tablet, Film Coated
NDC: 42747-602
Kyowa Kirin, Inc.
Nourianz 40 mg Oral Tablet, Film Coated
NDC: 42747-604
Kyowa Kirin, Inc.